148 related articles for article (PubMed ID: 36943497)
1. A prospective evaluation of patient-reported outcomes during follow-up of ureteral stones managed with medical expulsive treatment (MET).
Pandey A; Mandal S; Kumaraswamy S; Gaur AS; Das MK; Nayak P
Urolithiasis; 2023 Mar; 51(1):56. PubMed ID: 36943497
[TBL] [Abstract][Full Text] [Related]
2. Alpha-blockers as medical expulsive therapy for ureteral stones.
Campschroer T; Zhu Y; Duijvesz D; Grobbee DE; Lock MT
Cochrane Database Syst Rev; 2014 Apr; (4):CD008509. PubMed ID: 24691989
[TBL] [Abstract][Full Text] [Related]
3. Medical Expulsive Therapy for Symptomatic Distal Ureter Stones: Is the Combination of Bromelain and Tamsulosin More Effective than Tamsulosin Alone? Preliminary Results of a Single-Center Study.
Palmisano F; Spinelli MG; Luzzago S; Boeri L; De Lorenzis E; Albo G; Gadda F; Gelosa M; Longo F; Dell'Orto PG; Montanari E
Urol Int; 2019; 102(2):145-152. PubMed ID: 30227429
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous nephrostomy vs ureteral stent for hydronephrosis secondary to ureteric calculi: impact on spontaneous stone passage and health-related quality of life-a prospective study.
de Sousa Morais N; Pereira JP; Mota P; Carvalho-Dias E; Torres JN; Lima E
Urolithiasis; 2019 Dec; 47(6):567-573. PubMed ID: 30219938
[TBL] [Abstract][Full Text] [Related]
5. Computed tomography findings predicting the success of silodosin for medical expulsive therapy of ureteral stones.
Celik S; Akdeniz F; Yildirim MA; Bozkurt O; Bulut MG; Hacihasanoglu ML; Demir O
Kaohsiung J Med Sci; 2017 Jun; 33(6):290-294. PubMed ID: 28601233
[TBL] [Abstract][Full Text] [Related]
6. Silodosin to facilitate passage of ureteral stones: a multi-institutional, randomized, double-blinded, placebo-controlled trial.
Sur RL; Shore N; L'Esperance J; Knudsen B; Gupta M; Olsen S; Shah O
Eur Urol; 2015 May; 67(5):959-64. PubMed ID: 25465978
[TBL] [Abstract][Full Text] [Related]
7. Alpha-blockers as medical expulsive therapy for ureteral stones.
Campschroer T; Zhu X; Vernooij RW; Lock MT
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD008509. PubMed ID: 29620795
[TBL] [Abstract][Full Text] [Related]
8. The role of inflammatory serum markers and ureteral wall thickness on spontaneous passage of ureteral stone < 10 mm: A prospective cohort study.
Aghaways I; Ibrahim R; Bapir R; Salih RQ; Salih KM; Abdulla BA
Ann Med Surg (Lond); 2022 Aug; 80():104198. PubMed ID: 36045783
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with spontaneous stone passage in a contemporary cohort of patients presenting with acute ureteric colic: results from the Multi-centre cohort study evaluating the role of Inflammatory Markers In patients presenting with acute ureteric Colic (MIMIC) study.
Shah TT; Gao C; Peters M; Manning T; Cashman S; Nambiar A; Cumberbatch M; Lamb B; Peacock A; Van Son MJ; van Rossum PSN; Pickard R; Erotocritou P; Smith D; Kasivisvanathan V;
BJU Int; 2019 Sep; 124(3):504-513. PubMed ID: 31001912
[TBL] [Abstract][Full Text] [Related]
10. Significance of Neutrophil-to-Lymphocyte Ratio as a Novel Indicator of Spontaneous Ureter Stone Passage.
Lee KS; Ha JS; Koo KC
Yonsei Med J; 2017 Sep; 58(5):988-993. PubMed ID: 28792143
[TBL] [Abstract][Full Text] [Related]
11. CT-related parameters and Framingham score as predictors of spontaneous passage of ureteral stones ≤ 10 mm: results from a prospective, observational, multicenter study.
Selvi I; Baydilli N; Tokmak TT; Akinsal EC; Basar H
Urolithiasis; 2021 Jun; 49(3):227-237. PubMed ID: 32980972
[TBL] [Abstract][Full Text] [Related]
12. Early hospital admission and treatment onset may positively affect spontaneous passage of ureteral stones in patients with renal colic.
Sfoungaristos S; Kavouras A; Kanatas P; Duvdevani M; Perimenis P
Urology; 2014 Jul; 84(1):16-21. PubMed ID: 24685060
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Mirabegron as Medical Expulsive Therapy for Distal Ureteral Stones: A Prospective, Randomized, Double-Blinded, Controlled Study.
Morsy S; Nasser I; Aboulela W; Abdelazim MS; Ali H
Urol Int; 2022; 106(12):1265-1271. PubMed ID: 35100594
[TBL] [Abstract][Full Text] [Related]
14. Medical expulsive therapy using alfuzosin for patient presenting with ureteral stone less than 10mm: a prospective randomized controlled trial.
Chau LH; Tai DC; Fung BT; Li JC; Fan CW; Li MK
Int J Urol; 2011 Jul; 18(7):510-4. PubMed ID: 21592234
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal stone diameter on coronal reconstruction of computed tomography as a predictor of ureteral stone expulsion in medical expulsive therapy.
Lee SR; Jeon HG; Park DS; Choi YD
Urology; 2012 Oct; 80(4):784-9. PubMed ID: 22901820
[TBL] [Abstract][Full Text] [Related]
16. Predictive parameters for medical expulsive therapy in ureteral stones: a critical evaluation.
Sahin C; Eryildirim B; Kafkasli A; Coskun A; Tarhan F; Faydaci G; Sarica K
Urolithiasis; 2015 Jun; 43(3):271-5. PubMed ID: 25820291
[TBL] [Abstract][Full Text] [Related]
17. Development of a new scoring system predicting medical expulsive therapy success on 4-10 mm distal ureteral stones: medical expulsive therapy stone score (METSS).
Uzun E; Arabaci HB; Ceviz K; Koudonas A; Germiyanoglu RC; Senel S
Urolithiasis; 2023 Nov; 52(1):8. PubMed ID: 38015235
[TBL] [Abstract][Full Text] [Related]
18. Tadalafil versus alpha blockers (alfuzosin, doxazosin, tamsulosin and silodosin) as medical expulsive therapy for < 10 mm distal and proximal ureteral stones.
Çelik S; Akdeniz F; Afsar Yildirim M; Bozkurt O; Gursoy Bulut M; Hacihasanoglu ML; Demir O
Arch Ital Urol Androl; 2018 Jun; 90(2):117-122. PubMed ID: 29974727
[TBL] [Abstract][Full Text] [Related]
19. Cessation of Ureteral Colic Does Not Necessarily Mean that a Ureteral Stone Has Been Expelled.
Hernandez N; Mozafarpour S; Song Y; Eisner BH
J Urol; 2018 Apr; 199(4):1011-1014. PubMed ID: 29107030
[TBL] [Abstract][Full Text] [Related]
20. Resolution of Hydronephrosis and Pain to Predict Stone Passage for Patients With Acute Renal Colic.
Jackman SV; Maganty A; Wolfson AB; Burrows PK; MacPherson C; Vargas NM; Kirkali Z; Meltzer AC
Urology; 2022 Jan; 159():48-52. PubMed ID: 34627871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
